Publications 2023

Kalla R, Adams AT, Nowak JK, Bergemalm D, Vatn S, Ventham NT, Kennedy NA, Ricanek P, Lindstrom J, , Söderholm J, Pierik M, D'Amato M, Gomollón F, Olbjørn C, Richmond R, Relton C, Jahnsen J, Vatn MH, Halfvarson J, Satsangi J (2023)
Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome
J Crohns Colitis, 17 (2), 170-184
DOI 10.1093/ecco-jcc/jjac127, PubMed 36029471

Publications 2022

Nowak JK, Adams AT, Kalla R, Lindstrøm JC, Vatn S, Bergemalm D, Keita ÅV, Gomollón F, Jahnsen J, Vatn MH, Ricanek P, Ostrowski J, Walkowiak J, Halfvarson J, Satsangi J, (2022)
Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2
J Crohns Colitis, 16 (8), 1255-1268
DOI 10.1093/ecco-jcc/jjac033, PubMed 35212366

Vatn SS, Lindstrøm JC, Moen AEF, Brackmann S, Tannæs TM, Olbjørn C, Bergemalm D, Keita ÅV, Gomollon F, Detlie TE, Lüders T, Kalla R, Adams A, Satsangi J, Jahnsen J, Vatn MH, Halfvarson J, Ricanek P, Nilsen H, IBD-CHARACTER consortium (2022)
Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort
Clin Exp Gastroenterol, 15, 5-25
DOI 10.2147/CEG.S343468, PubMed 35185343

Publications 2021

Gearry RB, McCombie AM, Vatn M, Rubin DT, Steinwurz F, Loftus EV, Kruis W, Tysk C, Colombel JF, Ng SC, Van Assche G, Bernstein CN (2021)
What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing Countries
Inflamm Intest Dis, 6 (2), 78-86
DOI 10.1159/000512310, PubMed 34124179

Kalla R, Adams AT, Bergemalm D, Vatn S, Kennedy NA, Ricanek P, Lindstrom J, Ocklind A, Hjelm F, Ventham NT, Ho GT, Petren C, Repsilber D, Söderholm J, Pierik M, D'Amato M, Gomollón F, Olbjorn C, Jahnsen J, Vatn MH, Halfvarson J, Satsangi J (2021)
Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease
J Crohns Colitis, 15 (5), 699-708
DOI 10.1093/ecco-jcc/jjaa230, PubMed 33201212

Monstad IL, Solberg IC, Cvancarova M, Hovde O, Henriksen M, Huppertz-Hauss G, Gunther E, Moum BA, Stray N, Vatn M, Hoie O, Jahnsen J (2021)
Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study
J Crohns Colitis, 15 (6), 969-979
DOI 10.1093/ecco-jcc/jjaa232, PubMed 33367569

Publications 2020

Bengtson MB, Haugen M, Brantsæter AL, Aamodt G, Vatn MH (2020)
Intake of dairy protein during pregnancy in IBD and risk of SGA in a Norwegian population-based mother and child cohort
BMC Gastroenterol, 20 (1), 28
DOI 10.1186/s12876-020-1182-y, PubMed 32013916

Garshol BF, Aamodt G, Madsen C, Vatn MH, Bengtson MB (2020)
The effect of nitrogen dioxide on low birth weight in women with inflammatory bowel disease: a Norwegian pregnancy cohort study (MoBa)
Scand J Gastroenterol, 55 (3), 272-278
DOI 10.1080/00365521.2020.1726446, PubMed 32064969

Kalla R, Adams AT, Ventham NT, Kennedy NA, White R, Clarke C, Ivens A, Bergemalm D, Vatn S, Lopez-Jimena B, IBD Character Consortium, Ricanek P, Vatn MH, Söderholm JD, Gomollón F, Nowak JK, Jahnsen J, Halfvarson J, McTaggart S, Ho GT, Buck A, Satsangi J (2020)
Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease
J Crohns Colitis, 14 (12), 1724-1733
DOI 10.1093/ecco-jcc/jjaa134, PubMed 32598439

Klepp P, Brackmann S, Cvancarova M, Hoivik ML, Hovde Ø, Henriksen M, Huppertz-Hauss G, Bernklev T, Hoie O, Kempski-Monstad I, Solberg IC, Stray N, Jahnsen J, Vatn MH, Moum B (2020)
Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study
BMJ Open Gastroenterol, 7 (1), e000361
DOI 10.1136/bmjgast-2019-000361, PubMed 32337058

Kristensen VA, Cvancarova M, Høivik ML, Moum B, Vatn MH (2020)
Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study
Scand J Gastroenterol, 55 (4), 436-441
DOI 10.1080/00365521.2020.1745879, PubMed 32252542

Vatn S, Carstens A, Kristoffersen AB, Bergemalm D, Casén C, Moen AEF, Tannaes TM, Lindstrøm J, Detlie TE, Olbjørn C, Lindquist CM, Söderholm JD, Gomollón F, Kalla R, Satsangi J, Vatn MH, Jahnsen J, Halfvarson J, Ricanek P, IBD-Character Consortium (2020)
Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)
Scand J Gastroenterol, 55 (10), 1146-1156
DOI 10.1080/00365521.2020.1803396, PubMed 32780604

Publications 2019

Lunder AK, Bakstad LT, Jahnsen J, Borthne A, Hov JR, Vatn M, Negård A (2019)
Assessment of Bowel Inflammation and Strictures by Magnetic Resonance Enterography in Long-term Crohn's Disease
J Crohns Colitis, 13 (5), 607-614
DOI 10.1093/ecco-jcc/jjy208, PubMed 30541145

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Jahnsen J, Ricanek P, Vatn S, Moen AEF, Tannæs TM, Lindstrøm JC, Söderholm JD, Halfvarson J, Gomollón F, Casén C, Karlsson MK, Kalla R, Adams AT, Satsangi J, Perminow G (2019)
Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome
Clin Exp Gastroenterol, 12, 37-49
DOI 10.2147/CEG.S186235, PubMed 30774408

Publications 2018

Chauhan A, Lalor T, Watson S, Adams D, Farrah TE, Anand A, Kimmitt R, Mills NL, Webb DJ, Dhaun N, Kalla R, Adams A, Vatn S, Bonfliglio F, Nimmo E, Kennedy N, Ventham N, Vatn M, Ricanek P, Halfvarson J, Soderhollm J, Pierik M, Torkvist L, Gomollon F, Gut I et al. (2018)
Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland
QJM, 111 (12), 920-924
DOI 10.1093/qjmed/hcy193, PubMed 31222346

Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Lekven J, Schneede J, Tveit KM, Vatn M, Ursin G, Hoff G, NORCCAP Study Group† (2018)
Long-Term Effectiveness of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality in Women and Men: A Randomized Trial
Ann Intern Med, 168 (11), 775-782
DOI 10.7326/M17-1441, PubMed 29710125

Klepp P, Kisiel JB, Småstuen MC, Røseth A, Andersen SN, Vatn MH, Ahlquist DA, Moum BA, Brackmann S (2018)
Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study
Scand J Gastroenterol, 53 (3), 273-278
DOI 10.1080/00365521.2018.1424935, PubMed 29313389

Klepp P, Tollisen A, Røseth A, Cvancarova Småstuen M, Andersen SN, Vatn M, Moum BA, Brackmann S (2018)
Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis
World J Gastroenterol, 24 (35), 4069-4076
DOI 10.3748/wjg.v24.i35.4069, PubMed 30254411

Moen AEF, Lindstrøm JC, Tannæs TM, Vatn S, Ricanek P, Vatn MH, Jahnsen J, IBD-Character Consortium (2018)
The prevalence and transcriptional activity of the mucosal microbiota of ulcerative colitis patients
Sci Rep, 8 (1), 17278
DOI 10.1038/s41598-018-35243-4, PubMed 30467421

Ossum AM, Palm Ø, Cvancarova M, Solberg IC, Vatn M, Moum B, Høivik ML, IBSEN study group (2018)
Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study
Scand J Gastroenterol, 53 (10-11), 1250-1256
DOI 10.1080/00365521.2018.1518482, PubMed 30353756

Tronstad RR, Polushina T, Brattbakk HR, Stansberg C, von Volkmann HL, Hanevik K, Ellinghaus E, Jørgensen SF, Ersland KM, Pham KD, Gilja OH, Hovdenak N, Hausken T, Vatn MH, Franke A, Knappskog PM, Le Hellard S, Karlsen TH, Fiskerstrand T (2018)
Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea
Scand J Gastroenterol, 53 (10-11), 1264-1273
DOI 10.1080/00365521.2018.1521867, PubMed 30353760

Publications 2017

Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U (2017)
Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort
Dig Dis Sci, 62 (8), 2063-2069
DOI 10.1007/s10620-017-4547-5, PubMed 28332106

Bengtson MB, Aamodt G, Mahadevan U, Vatn MH (2017)
Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study
Inflamm Bowel Dis, 23 (7), 1225-1233
DOI 10.1097/MIB.0000000000001123, PubMed 28452861

Lunder AK, Jahnsen J, Bakstad LT, Borthne A, Hov JR, Vatn M, Negård A, IBSEN Study Group (2017)
Bowel Damage in Patients With Long-term Crohn's Disease, Assessed by Magnetic Resonance Enterography and the Lémann Index
Clin Gastroenterol Hepatol, 16 (1), 75-82.e5
DOI 10.1016/j.cgh.2017.06.053, PubMed 28694130

Myklebust-Hansen T, Aamodt G, Haugen M, Brantsæter AL, Vatn MH, Bengtson MB (2017)
Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa)
Inflamm Bowel Dis, 24 (1), 12-24
DOI 10.1093/ibd/izx006, PubMed 29272477

Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F (2017)
Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
J Hepatol, 66 (6), 1214-1222
DOI 10.1016/j.jhep.2017.01.019, PubMed 28161472

Publications 2016

Hov JR, Boberg KM, Taraldsrud E, Vesterhus M, Boyadzhieva M, Solberg IC, Schrumpf E, Vatn MH, Lie BA, Molberg Ø, Karlsen TH (2016)
Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis
Liver Int, 37 (3), 458-465
DOI 10.1111/liv.13238, PubMed 27558072

Lunder AK, Hov JR, Borthne A, Gleditsch J, Johannesen G, Tveit K, Viktil E, Henriksen M, Hovde Ø, Huppertz-Hauss G, Høie O, Høivik ML, Monstad I, Solberg IC, Jahnsen J, Karlsen TH, Moum B, Vatn M, Negård A (2016)
Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease
Gastroenterology, 151 (4), 660-669.e4
DOI 10.1053/j.gastro.2016.06.021, PubMed 27342213

Moen AE, Tannæs TM, Vatn S, Ricanek P, Vatn MH, Jahnsen J, IBD-Character Consortium (2016)
Simultaneous purification of DNA and RNA from microbiota in a single colonic mucosal biopsy
BMC Res Notes, 9, 328
DOI 10.1186/s13104-016-2110-7, PubMed 27352784

Olbjørn C, Cvancarova Småstuen M, Thiis-Evensen E, Nakstad B, Vatn MH, Perminow G (2016)
Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy
Scand J Gastroenterol, 52 (4), 414-419
DOI 10.1080/00365521.2016.1259653, PubMed 27887202

Publications 2015

Bengtson MB, Aamodt G, Vatn MH, Harris JR (2015)
Co-occurrence of IBS and symptoms of anxiety or depression, among Norwegian twins, is influenced by both heredity and intrauterine growth
BMC Gastroenterol, 15, 9
DOI 10.1186/s12876-015-0237-y, PubMed 25649866

Casén C, Vebø HC, Sekelja M, Hegge FT, Karlsson MK, Ciemniejewska E, Dzankovic S, Frøyland C, Nestestog R, Engstrand L, Munkholm P, Nielsen OH, Rogler G, Simrén M, Öhman L, Vatn MH, Rudi K (2015)
Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
Aliment Pharmacol Ther, 42 (1), 71-83
DOI 10.1111/apt.13236, PubMed 25973666

Kevans D, Tyler AD, Holm K, Jørgensen KK, Vatn MH, Karlsen TH, Kaplan GG, Eksteen B, Gevers D, Hov JR, Silverberg MS (2015)
Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis
J Crohns Colitis, 10 (3), 330-7
DOI 10.1093/ecco-jcc/jjv204, PubMed 26526357

Ricanek P, Lunde LK, Frye SA, Støen M, Nygård S, Morth JP, Rydning A, Vatn MH, Amiry-Moghaddam M, Tønjum T (2015)
Reduced expression of aquaporins in human intestinal mucosa in early stage inflammatory bowel disease
Clin Exp Gastroenterol, 8, 49-67
DOI 10.2147/CEG.S70119, PubMed 25624769

Vatn MH, Sandvik AK (2015)
Inflammatory bowel disease
Scand J Gastroenterol, 50 (6), 748-62
DOI 10.3109/00365521.2015.1033000, PubMed 25855003

Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygård S, Godang K, Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH, Lund-Johansen F, Syversveen T, Brabrand K, Parés A, Ponsioen CY, Pinzani M, Färkkilä M, Moum B, Ueland T, Røsjø H, Rosenberg W, Boberg KM, Karlsen TH (2015)
Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
Hepatology, 62 (1), 188-97
DOI 10.1002/hep.27825, PubMed 25833813

Publications 2014

Beisner J, Teltschik Z, Ostaff MJ, Tiemessen MM, Staal FJ, Wang G, Gersemann M, Perminow G, Vatn MH, Schwab M, Stange EF, Wehkamp J (2014)
TCF-1-mediated Wnt signaling regulates Paneth cell innate immune defense effectors HD-5 and -6: implications for Crohn's disease
Am J Physiol Gastrointest Liver Physiol, 307 (5), G487-98
DOI 10.1152/ajpgi.00347.2013, PubMed 24994854

Boyar Cetinkaya R, Vatn M, Aabakken L, Bergestuen DS, Thiis-Evensen E (2014)
Survival and prognostic factors in well-differentiated pancreatic neuroendocrine tumors
Scand J Gastroenterol, 49 (6), 734-41
DOI 10.3109/00365521.2014.903432, PubMed 24679166

Olbjørn C, Nakstad B, Småstuen MC, Thiis-Evensen E, Vatn MH, Perminow G (2014)
Early anti-TNF treatment in pediatric Crohn's disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients
Scand J Gastroenterol, 49 (12), 1425-31
DOI 10.3109/00365521.2014.966316, PubMed 25310799

Solberg IC, Cvancarova M, Vatn MH, Moum B, IBSEN Study Group (2014)
Risk matrix for prediction of advanced disease in a population-based study of patients with Crohn's Disease (the IBSEN Study)
Inflamm Bowel Dis, 20 (1), 60-8
DOI 10.1097/01.MIB.0000436956.78220.67, PubMed 24280875

Publications 2013

Block M, Jørgensen KK, Oresland T, Lindholm E, Grzyb K, Cvancarova M, Vatn MH, Boberg KM, Börjesson L (2013)
Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?
J Crohns Colitis, 8 (5), 421-30
DOI 10.1016/j.crohns.2013.10.008, PubMed 24239402

Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, Laerdahl JK, Shiryaev A, Gotthardt DN, Weismüller TJ, Schramm C, Wittig M, Bergquist A, Björnsson E, Marschall HU, Vatn M, Teufel A, Rust C, Gieger C, Wichmann HE, Runz H, Sterneck M, Rupp C, Braun F, Weersma RK et al. (2013)
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4
Hepatology, 58 (3), 1074-83
DOI 10.1002/hep.25977, PubMed 22821403

Ellinghaus D, Zhang H, Zeissig S, Lipinski S, Till A, Jiang T, Stade B, Bromberg Y, Ellinghaus E, Keller A, Rivas MA, Skieceviciene J, Doncheva NT, Liu X, Liu Q, Jiang F, Forster M, Mayr G, Albrecht M, Häsler R, Boehm BO, Goodall J, Berzuini CR, Lee J, Andersen V et al. (2013)
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies
Gastroenterology, 145 (2), 339-47
DOI 10.1053/j.gastro.2013.04.040, PubMed 23624108

Gedde-Dahl M, Thiis-Evensen E, Tjølsen AM, Mordal KS, Vatn M, Bergestuen DS (2013)
Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
Endocr Connect, 2 (1), 50-4
DOI 10.1530/EC-12-0077, PubMed 23781318

Haugland T, Veenstra M, Vatn MH, Wahl AK (2013)
Improvement in Stress, General Self-Efficacy, and Health Related Quality of Life following Patient Education for Patients with Neuroendocrine Tumors: A Pilot Study
Nurs Res Pract, 2013, 695820
DOI 10.1155/2013/695820, PubMed 23738063

Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2013)
Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease
Clin Gastroenterol Hepatol, 11 (5), 517-23
DOI 10.1016/j.cgh.2012.12.027, PubMed 23333218

Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S et al. (2013)
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
Nat Genet, 45 (6), 670-5
DOI 10.1038/ng.2616, PubMed 23603763

Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O'Morain C, Moum B, Colombel JF, Epidemiology and Natural History Task Force of the International Organization of Inflammatory Bowel Disease (IOIBD) (2013)
Geographical variability and environmental risk factors in inflammatory bowel disease
Gut, 62 (4), 630-49
DOI 10.1136/gutjnl-2012-303661, PubMed 23335431

Nwosu FC, Thorkildsen LT, Avershina E, Ricanek P, Perminow G, Brackmann S, Vatn MH, Rudi K (2013)
Age-dependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children
Gastroenterol Res Pract, 2013, 302398
DOI 10.1155/2013/302398, PubMed 23690761

Rogler G, Aldeguer X, Kruis W, Lasson A, Mittmann U, Nally K, Peyrin-Biroulet L, Schoepfer A, Vatn M, Vavricka S, Logan R (2013)
Concept for a rapid point-of-care calprotectin diagnostic test for diagnosis and disease activity monitoring in patients with inflammatory bowel disease: expert clinical opinion
J Crohns Colitis, 7 (8), 670-7
DOI 10.1016/j.crohns.2013.02.014, PubMed 23517932

Thorkildsen LT, Nwosu FC, Avershina E, Ricanek P, Perminow G, Brackmann S, Vatn MH, Rudi K (2013)
Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients
Gastroenterol Res Pract, 2013, 636785
DOI 10.1155/2013/636785, PubMed 24348539

Aamodt G, Bengtson MB, Vatn MH (2013)
Can temperature explain the latitudinal gradient of ulcerative colitis? Cohort of Norway
BMC Public Health, 13, 530
DOI 10.1186/1471-2458-13-530, PubMed 23724802

Publications 2012

Berstad P, Thiis-Evensen E, Vatn MH, Almendingen K (2012)
Fatty acids in habitual diet, plasma phospholipids, and tumour and normal colonic biopsies in young colorectal cancer patients
J Oncol, 2012, 254801
DOI 10.1155/2012/254801, PubMed 23319946

Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM (2012)
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study
Scand J Gastroenterol, 47 (8-9), 1021-9
DOI 10.3109/00365521.2012.685754, PubMed 22577871

Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017

Ricanek P, Lothe SM, Frye SA, Rydning A, Vatn MH, Tønjum T (2012)
Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn's disease
Clin Exp Gastroenterol, 5, 173-86
DOI 10.2147/CEG.S33858, PubMed 23049264

Rolny P, Vatn M (2012)
Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article
Scand J Gastroenterol, 48 (2), 131-5
DOI 10.3109/00365521.2012.733954, PubMed 23110487

Publications 2011

Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, Taylor KD, Lee JC, Goyette P, Imielinski M, Latiano A, Lagacé C, Scott R, Amininejad L, Bumpstead S, Baidoo L, Baldassano RN, Barclay M, Bayless TM, Brand S, Büning C, Colombel JF, Denson LA, De Vos M, Dubinsky M, Edwards C et al. (2011)
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
Nat Genet, 43 (3), 246-52
DOI 10.1038/ng.764, PubMed 21297633

Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D'Haens G, Dotan I, Goh KL, Hibi T, Kozarek RA, Quigley EM, Reinisch W, Sands BE, Sollano JD, Steinhart AH, Steinwurz F, Vatn MH, Yamamoto-Furusho JK (2011)
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting
Inflamm Bowel Dis, 17 (2), 639-44
DOI 10.1002/ibd.21409, PubMed 20725944

Hoivik ML, Moum B, Solberg IC, Cvancarova M, Hoie O, Vatn MH, Bernklev T, IBSEN Study Group (2011)
Health-related quality of life in patients with ulcerative colitis after a 10-year disease course: results from the IBSEN study
Inflamm Bowel Dis, 18 (8), 1540-9
DOI 10.1002/ibd.21863, PubMed 21936030

Jørgensen KK, Grzyb K, Lundin KE, Clausen OP, Aamodt G, Schrumpf E, Vatn MH, Boberg KM (2011)
Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients
Inflamm Bowel Dis, 18 (3), 536-45
DOI 10.1002/ibd.21699, PubMed 21456044

Reikvam DH, Perminow G, Lyckander LG, Gran JM, Brandtzaeg P, Vatn M, Carlsen HS (2011)
Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients
Scand J Gastroenterol, 46 (5), 550-60
DOI 10.3109/00365521.2011.551887, PubMed 21281255

Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, Høie O, Rydning A, Vatn MH, IBSEN II Study Group (2011)
Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers
Scand J Gastroenterol, 46 (9), 1081-91
DOI 10.3109/00365521.2011.584897, PubMed 21619483

Ricanek P, Rydning A, Vatn MH, Tonjum T (2011)
Considered "negative" for MAP, these results would be very "positive" for tuberculoid leprosy Reply
J. Crohns Colitis, 5 (4), 374
DOI 10.1016/j.crohns.2011.04.007

Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI (2011)
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
Genes Immun, 12 (8), 653-62
DOI 10.1038/gene.2011.43, PubMed 21716316

Publications 2010

Bengtson MB, Solberg IC, Aamodt G, Jahnsen J, Moum B, Vatn MH, IBSEN Study Group (2010)
Relationships between inflammatory bowel disease and perinatal factors: both maternal and paternal disease are related to preterm birth of offspring
Inflamm Bowel Dis, 16 (5), 847-55
DOI 10.1002/ibd.21120, PubMed 19795509

Bengtson MB, Aamodt G, Vatn MH, Harris JR (2010)
Concordance for IBD among twins compared to ordinary siblings--a Norwegian population-based study
J Crohns Colitis, 4 (3), 312-8
DOI 10.1016/j.crohns.2009.12.008, PubMed 21122520

Berg M, Agesen TH, Thiis-Evensen E, INFAC-study group, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, Skotheim RI, Lothe RA (2010)
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci
Mol Cancer, 9, 100
DOI 10.1186/1476-4598-9-100, PubMed 20459617

Berg M, Danielsen SA, Ahlquist T, Merok MA, Ågesen TH, Vatn MH, Mala T, Sjo OH, Bakka A, Moberg I, Fetveit T, Mathisen Ø, Husby A, Sandvik O, Nesbakken A, Thiis-Evensen E, Lothe RA (2010)
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset
PLoS One, 5 (11), e13978
DOI 10.1371/journal.pone.0013978, PubMed 21103049

Bergestuen DS, Edvardsen T, Aakhus S, Ueland T, Oie E, Vatn M, Aukrust P, Thiis-Evensen E (2010)
Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis
Neuroendocrinology, 92 (3), 168-77
DOI 10.1159/000318014, PubMed 20720391

Brackmann S, Aamodt G, Andersen SN, Roald B, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH (2010)
Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer
Inflamm Bowel Dis, 16 (3), 474-81
DOI 10.1002/ibd.21053, PubMed 19714748

Franke A, Balschun T, Sina C, Ellinghaus D, Häsler R, Mayr G, Albrecht M, Wittig M, Buchert E, Nikolaus S, Gieger C, Wichmann HE, Sventoraityte J, Kupcinskas L, Onnie CM, Gazouli M, Anagnou NP, Strachan D, McArdle WL, Mathew CG, Rutgeerts P, Vermeire S, Vatn MH, IBSEN study group, Krawczak M et al. (2010)
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL)
Nat Genet, 42 (4), 292-4
DOI 10.1038/ng.553, PubMed 20228798

Hov JR, Keitel V, Laerdahl JK, Spomer L, Ellinghaus E, ElSharawy A, Melum E, Boberg KM, Manke T, Balschun T, Schramm C, Bergquist A, Weismüller T, Gotthardt D, Rust C, Henckaerts L, Onnie CM, Weersma RK, Sterneck M, Teufel A, Runz H, Stiehl A, Ponsioen CY, Wijmenga C, Vatn MH et al. (2010)
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis
PLoS One, 5 (8), e12403
DOI 10.1371/journal.pone.0012403, PubMed 20811628

Ricanek P, Lothe SM, Szpinda I, Jorde AT, Brackmann S, Perminow G, Jørgensen KK, Rydning A, Vatn MH, Tønjum T, IBSEN II study group (2010)
Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease
J Crohns Colitis, 4 (5), 561-6
DOI 10.1016/j.crohns.2010.05.003, PubMed 21122560

Rudi K, Berg F, Gaustad E, Tannes T, Vatn M (2010)
Ratios between Alpha-, Beta- and Gamma-proteobacteria in tap water determined by the ProteoQuant assay
Lett Appl Microbiol, 50 (1), 1-6
DOI 10.1111/j.1472-765X.2009.02743.x, PubMed 19874479

Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM, Vatn MH, Haraldsen G (2010)
Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts
Am J Pathol, 177 (6), 2804-15
DOI 10.2353/ajpath.2010.100378, PubMed 21037074

Publications 2009

Almendingen K, Fausa O, Høstmark AT, Bratlie J, Mørkerid L, Aabakken L, Vatn MH (2009)
Serum nutrients and habitual dietary intake in colectomized FAP patients in Norway
Eur J Nutr, 48 (3), 129-36
DOI 10.1007/s00394-008-0772-1, PubMed 19142564

Bengtson MB, Solberg C, Aamodt G, Jahnsen J, Moum B, Sauar J, Vatn MH, Ibsen Study Group (2009)
Clustering in time of familial IBD separates ulcerative colitis from Crohn's disease
Inflamm Bowel Dis, 15 (12), 1867-74
DOI 10.1002/ibd.20978, PubMed 19434721

Bergestuen DS, Aabakken L, Holm K, Vatn M, Thiis-Evensen E (2009)
Small intestinal neuroendocrine tumors: prognostic factors and survival
Scand J Gastroenterol, 44 (9), 1084-91
DOI 10.1080/00365520903082432, PubMed 19572232

Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH (2009)
Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease
Scand J Gastroenterol, 44 (1), 46-55
DOI 10.1080/00365520801977568, PubMed 18609187

Brackmann S, Andersen SN, Aamodt G, Roald B, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH (2009)
Two distinct groups of colorectal cancer in inflammatory bowel disease
Inflamm Bowel Dis, 15 (1), 9-16
DOI 10.1002/ibd.20542, PubMed 18618636

Haugland T, Vatn MH, Veenstra M, Wahl AK, Natvig GK (2009)
Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population
Qual Life Res, 18 (6), 719-26
DOI 10.1007/s11136-009-9487-x, PubMed 19479341

Holme O, Thiis-Evensen E, Vatn MH (2009)
Treatment of fulminant ulcerative colitis with cyclosporine A
Scand J Gastroenterol, 44 (11), 1310-4
DOI 10.3109/00365520903222673, PubMed 19891581

Perminow G, Beisner J, Koslowski M, Lyckander LG, Stange E, Vatn MH, Wehkamp J (2009)
Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease
Am J Gastroenterol, 105 (2), 452-9
DOI 10.1038/ajg.2009.643, PubMed 19904243

Perminow G, Brackmann S, Lyckander LG, Franke A, Borthne A, Rydning A, Aamodt G, Schreiber S, Vatn MH, IBSEN-II Group (2009)
A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease
Scand J Gastroenterol, 44 (4), 446-56
DOI 10.1080/00365520802647434, PubMed 19117240

Perminow G, Reikvam DH, Lyckander LG, Brandtzaeg P, Vatn MH, Carlsen HS (2009)
Increased number and activation of colonic macrophages in pediatric patients with untreated Crohn's disease
Inflamm Bowel Dis, 15 (9), 1368-78
DOI 10.1002/ibd.20916, PubMed 19322902

Rudi K, Tannaes T, Vatn M (2009)
Temporal and spatial diversity of the tap water microbiota in a Norwegian hospital
Appl Environ Microbiol, 75 (24), 7855-7
DOI 10.1128/AEM.01174-09, PubMed 19837845

Solberg IC, Lygren I, Cvancarova M, Jahnsen J, Stray N, Sauar J, Schreiber S, Moum B, Vatn MH, IBSEN Study Group (2009)
Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease
Inflamm Bowel Dis, 15 (3), 406-14
DOI 10.1002/ibd.20781, PubMed 19009607

Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH, Moum B, IBSEN Study Group (2009)
Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)
Scand J Gastroenterol, 44 (4), 431-40
DOI 10.1080/00365520802600961, PubMed 19101844

Vatn MH (2009)
Mucosal healing: impact on the natural course or therapeutic strategies
Dig Dis, 27 (4), 470-5
DOI 10.1159/000233285, PubMed 19897962

Vatn MH (2009)
Natural history and complications of IBD
Curr Gastroenterol Rep, 11 (6), 481-7
DOI 10.1007/s11894-009-0073-8, PubMed 19903424

Publications 2008

Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA (2008)
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
Mol Cancer, 7, 94
DOI 10.1186/1476-4598-7-94, PubMed 19117505

Bengtson MB, Solberg C, Aamodt G, Sauar J, Jahnsen J, Moum B, Lygren I, Vatn MH, IBSEN study group (2008)
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years
J Crohns Colitis, 3 (2), 92-9
DOI 10.1016/j.crohns.2008.11.002, PubMed 21172251

Fjallskog ML, Janson ET, Falkmer UG, Vatn MH, Oberg KE, Eriksson BK (2008)
Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors
Neuroendocrinology, 88 (1), 53-8
DOI 10.1159/000117575, PubMed 18285678

Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH, IBSEN study group, Mathew CG et al. (2008)
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility
Nat Genet, 40 (11), 1319-23
DOI 10.1038/ng.221, PubMed 18836448

Geboes K, Colombel JF, Greenstein A, Jewell DP, Sandborn WJ, Vatn MH, Warren B, Riddell RH, Pathology Task Force of the International Organization of Inflammatory Bowel Diseases (2008)
Indeterminate colitis: a review of the concept--what's in a name?
Inflamm Bowel Dis, 14 (6), 850-7
DOI 10.1002/ibd.20361, PubMed 18213696

Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group (2008)
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
Gut, 57 (11), 1518-23
DOI 10.1136/gut.2007.146357, PubMed 18566104

Vatn MH (2008)
How do you judge relapse in Crohn's disease?
Inflamm Bowel Dis, 14 Suppl 2, S253-4
DOI 10.1002/ibd.20706, PubMed 18816713

Vatn MH (2008)
Recent Research in IBD Epidemiology
Gastroenterol Hepatol (N Y), 4 (6), 413-5
PubMed 21904517

Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn MH, IBSEN Study Group (2008)
The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway
Am J Epidemiol, 168 (9), 1065-72
DOI 10.1093/aje/kwn218, PubMed 18801890

Aamodt G, Jahnsen J, Bengtson MB, Moum B, Vatn MH, IBSEN Study Group (2008)
Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993
Inflamm Bowel Dis, 14 (7), 984-91
DOI 10.1002/ibd.20417, PubMed 18338775

Publications 2007

Almendingen K, Høstmark AT, Fausa O, Mosdøl A, Aabakken L, Vatn MH (2007)
Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids
Int J Cancer, 120 (3), 632-7
DOI 10.1002/ijc.22337, PubMed 17096349

Eike MC, Nordang GB, Karlsen TH, Boberg KM, Vatn MH, IBSEN study group, Dahl-Jørgensen K, Rønningen KS, Joner G, Flatø B, Bergquist A, Thorsby E, Førre O, Kvien TK, Undlien DE, Lie BA (2007)
The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases
Ann Rheum Dis, 67 (9), 1287-91
DOI 10.1136/ard.2007.077826, PubMed 18065500

Franke A, Rosenstiel P, Balschun T, Von Kampen O, Schreiber S, Sina C, Hampe J, Karlsen TH, Vatn MH, IBSEN Study Group, Solberg C (2007)
No association between the TUCAN (CARD8) Cys10Stop mutation and inflammatory bowel disease in a large retrospective German and a clinically well-characterized Norwegian sample
Gastroenterology, 132 (5), 2080-1
DOI 10.1053/j.gastro.2007.03.087, PubMed 17484912

Frøslie KF, Jahnsen J, Moum BA, Vatn MH, IBSEN Group (2007)
Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort
Gastroenterology, 133 (2), 412-22
DOI 10.1053/j.gastro.2007.05.051, PubMed 17681162

Førli L, Mellbye OJ, Halse J, Bjørtuft O, Vatn M, Boe J (2007)
Cytokines, bone turnover markers and weight change in candidates for lung transplantation
Pulm Pharmacol Ther, 21 (1), 188-95
DOI 10.1016/j.pupt.2007.02.002, PubMed 17419084

Henriksen M, Jahnsen J, Lygren I, Vatn MH, Moum B, IBSEN Study Group (2007)
Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study
Am J Gastroenterol, 102 (9), 1955-63
DOI 10.1111/j.1572-0241.2007.01368.x, PubMed 17573793

Henriksen M, Jahnsen J, Lygren I, Aadland E, Schulz T, Vatn MH, Moum B, Ibsen Study Group (2007)
Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study)
Scand J Gastroenterol, 42 (5), 602-10
DOI 10.1080/00365520601076124, PubMed 17454881

Höie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, Odes S, Mouzas IA, Beltrami M, Langholz E, Stockbrügger R, Vatn M, Moum B, European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD) (2007)
Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort
Am J Gastroenterol, 102 (8), 1692-701
DOI 10.1111/j.1572-0241.2007.01265.x, PubMed 17555460

Høie O, Aamodt G, Vermeire S, Bernklev T, Odes S, Wolters FL, Riis L, Politi P, Tsianos EV, Butrón M, Stockbrügger RW, Munkholm P, Vatn M, Moum B, European Collaborative study group of Inflammatory Bowel Disease (EC-IBD) (2007)
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years
J Crohns Colitis, 2 (2), 114-22
DOI 10.1016/j.crohns.2007.10.001, PubMed 21172201

Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA, IBSEN Study Group (2007)
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis
Genes Immun, 8 (3), 275-8
DOI 10.1038/sj.gene.6364377, PubMed 17301827

Katsanos KH, Vermeire S, Christodoulou DK, Riis L, Wolters F, Odes S, Freitas J, Hoie O, Beltrami M, Fornaciari G, Clofent J, Bodini P, Vatn M, Nunes PB, Moum B, Munkholm P, Limonard C, Stockbrugger R, Rutgeerts P, Tsianos EV, EC-IBD Study Group (2007)
Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study
Digestion, 75 (2-3), 113-21
DOI 10.1159/000104731, PubMed 17598963

Ljung T, Thomsen OØ, Vatn M, Karlén P, Karlsen LN, Tysk C, Nilsson SU, Kilander A, Gillberg R, Grip O, Lindgren S, Befrits R, Löfberg R (2007)
Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia
Scand J Gastroenterol, 42 (2), 221-7
DOI 10.1080/00365520600979369, PubMed 17327942

Odes S, Friger M, Vardi H, Claessens G, Bossuyt X, Riis L, Munkholm P, Wolters F, Yona H, Hoie O, Beltrami M, Tsianos E, Katsanos K, Mouzas I, Clofent J, Monteiro E, Messori A, Politi P, O'Morain C, Limonard C, Russel M, Vatn M, Moum B, Stockbrugger R, Vermeire S et al. (2007)
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel Disease
Inflamm Bowel Dis, 13 (7), 874-81
DOI 10.1002/ibd.20122, PubMed 17278126

Odes S, Vardi H, Friger M, Wolters F, Hoie O, Moum B, Bernklev T, Yona H, Russel M, Munkholm P, Langholz E, Riis L, Politi P, Bondini P, Tsianos E, Katsanos K, Clofent J, Vermeire S, Freitas J, Mouzas I, Limonard C, O'Morain C, Monteiro E, Fornaciari G, Vatn M et al. (2007)
Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification
J Crohns Colitis, 1 (2), 87-96
DOI 10.1016/j.crohns.2007.08.004, PubMed 21172190

Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I, IBSEN Study Group (2007)
Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study
Clin Gastroenterol Hepatol, 5 (12), 1430-8
DOI 10.1016/j.cgh.2007.09.002, PubMed 18054751

Wolters FL, Joling C, Russel MG, Sijbrandij J, De Bruin M, Odes S, Riis L, Munkholm P, Bodini P, Ryan B, O'Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C, Vatn M, Fornaciari G, Rodriguez D, Groot W, Moum B, Stockbrügger RW, European Collaborative Study Group On Inflammatory Bowel Disease (EC-IBD) (2007)
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease course
Scand J Gastroenterol, 42 (3), 333-44
DOI 10.1080/00365520600930750, PubMed 17354113

Publications 2006

Amundsen SS, Vatn M, IBSEN study group, Wijmenga C, Sollid LM, Lie BA (2006)
Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort
Tissue Antigens, 68 (3), 249-52
DOI 10.1111/j.1399-0039.2006.00665.x, PubMed 16948647

Bengtson MB, Rønning T, Vatn MH, Harris JR (2006)
Irritable bowel syndrome in twins: genes and environment
Gut, 55 (12), 1754-9
DOI 10.1136/gut.2006.097287, PubMed 17008364

Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B (2006)
Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease
Inflamm Bowel Dis, 12 (5), 402-12
DOI 10.1097/01.MIB.0000218762.61217.4a, PubMed 16670530

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM (2006)
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis
J Hepatol, 45 (5), 704-10
DOI 10.1016/j.jhep.2006.03.012, PubMed 16750586

Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold Ø, Schulz T, Vatn MH, Moum B, IBSEN Study Group (2006)
Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study)
Inflamm Bowel Dis, 12 (7), 543-50
DOI 10.1097/01.MIB.0000225339.91484.fc, PubMed 16804390

Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B, Ibsen Study Group (2006)
Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study)
Scand J Gastroenterol, 41 (9), 1037-43
DOI 10.1080/00365520600554527, PubMed 16938716

Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J, Tsianos E, Beltrami M, Odes S, Munkholm P, Vatn M, Stockbrügger RW, Moum B, European Collaborative Study Group of Inflammatory Bowel Disease (2006)
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years
Gastroenterology, 132 (2), 507-15
DOI 10.1053/j.gastro.2006.11.015, PubMed 17258717

Höie O, Schouten LJ, Wolters FL, Solberg IC, Riis L, Mouzas IA, Politi P, Odes S, Langholz E, Vatn M, Stockbrügger RW, Moum B, European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD) (2006)
Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis
Gut, 56 (4), 497-503
DOI 10.1136/gut.2006.101519, PubMed 17028127

Medici V, Mascheretti S, Croucher PJ, Stoll M, Hampe J, Grebe J, Sturniolo GC, Solberg C, Jahnsen J, Moum B, Schreiber S, Vatn MH (2006)
Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations
Eur J Hum Genet, 14 (4), 459-68
DOI 10.1038/sj.ejhg.5201576, PubMed 16493449

Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O'morain C, Moum B, Vatn M, Stockbrugger R, European Collaborative Study on Inflammatory Bowel Disease (2006)
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation
Gastroenterology, 131 (3), 719-28
DOI 10.1053/j.gastro.2006.05.052, PubMed 16952541

Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van ZG, O'Morain C, Moum B, Vatn M, Stockbrugger R (2006)
Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. (vol 131, pg 719, 2006)
Gastroenterology, 131 (6), 2029

Perminow G, Frigessi A, Rydning A, Nakstad B, Vatn MH (2006)
Incidence and clinical presentation of IBD in children: comparison between prospective and retrospective data in a selected Norwegian population
Scand J Gastroenterol, 41 (12), 1433-9
DOI 10.1080/00365520600789891, PubMed 17101574

Thiis-Evensen E, Seip B, Vatn MH, Hoff GS (2006)
Impact of a colonoscopic screening examination for colorectal cancer on later utilization of distal GI endoscopies
Gastrointest Endosc, 64 (6), 948-54
DOI 10.1016/j.gie.2006.08.006, PubMed 17140903

Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Langholz E, Bodini P, O'Morain C, Katsanos K, Tsianos E, Vermeire S, Van Zeijl G, Limonard C, Hoie O, Vatn M, Moum B, Stockbrügger RW, European Collaborative Study Group On Inflammatory Bowel Disease (2006)
Disease outcome of inflammatory bowel disease patients: general outline of a Europe-wide population-based 10-year clinical follow-up study
Scand J Gastroenterol Suppl (243), 46-54
DOI 10.1080/00365520600664250, PubMed 16782622

Publications 2005

Almendingen K, Brevik A, Nymoen DA, Hilmarsen HT, Andresen PA, Andersen LF, Vatn M (2005)
Modulation of COX-2 expression in peripheral blood cells by increased intake of fruit and vegetables?
Eur J Clin Nutr, 59 (4), 597-602
DOI 10.1038/sj.ejcn.1602110, PubMed 15741988

Bernklev T, Jahnsen J, Lygren I, Henriksen M, Vatn M, Moum B (2005)
Health-related quality of life in patients with inflammatory bowel disease measured with the short form-36: psychometric assessments and a comparison with general population norms
Inflamm Bowel Dis, 11 (10), 909-18
DOI 10.1097/01.mib.0000179467.01748.99, PubMed 16189421

Bernklev T, Jahnsen J, Schulz T, Sauar J, Lygren I, Henriksen M, Stray N, Kjellevold Ø, Aadland E, Vatn M, Moum B (2005)
Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis
Eur J Gastroenterol Hepatol, 17 (10), 1037-45
DOI 10.1097/00042737-200510000-00006, PubMed 16148548

Forli L, Mellbye OJ, Bjortuft O, Vatn M, Kofstad J, Boe J (2005)
Systemic inflammation and weight gain in underweight patients with advanced pulmonary disease
Nutr. Res., 25 (2), 119-131
DOI 10.1016/j.nutres.2004.12.001

Førli L, Moum T, Bjørtuft O, Vatn M, Boe J (2005)
The influence of underweight and dietary support on well-being in lung transplant candidates
Respir Med, 100 (7), 1239-46
DOI 10.1016/j.rmed.2005.10.016, PubMed 16311026

Laake KO, Bjørneklett A, Aamodt G, Aabakken L, Jacobsen M, Bakka A, Vatn MH (2005)
Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis
Scand J Gastroenterol, 40 (1), 43-51
DOI 10.1080/00365520410009339, PubMed 15841713

Olaussen RW, Løvik A, Tollefsen S, Andresen PA, Vatn MH, De Lange T, Bratlie J, Brandtzaeg P, Farstad IN, Lundin KE (2005)
Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease
Clin Gastroenterol Hepatol, 3 (9), 875-85
DOI 10.1016/s1542-3565(05)00295-8, PubMed 16234025

Schoon EJ, Bollani S, Mills PR, Israeli E, Felsenberg D, Ljunghall S, Persson T, Haptén-White L, Graffner H, Bianchi Porro G, Vatn M, Stockbrügger RW, Matrix Study Group (2005)
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease
Clin Gastroenterol Hepatol, 3 (2), 113-21
DOI 10.1016/s1542-3565(04)00662-7, PubMed 15704045

Wolters FL, Russel MG, Sijbrandij J, Schouten LJ, Odes S, Riis L, Munkholm P, Bodini P, O'Morain C, Mouzas IA, Tsianos E, Vermeire S, Monteiro E, Limonard C, Vatn M, Fornaciari G, Pereira S, Moum B, Stockbrügger RW, European Collaborative study group on Inflammatory Bowel Disease (EC-IBD) (2005)
Crohn's disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort
Gut, 55 (4), 510-8
DOI 10.1136/gut.2005.072793, PubMed 16150857

Publications 2004

Almendingen K, Hofstad B, Vatn MH (2004)
Dietary habits and growth and recurrence of colorectal adenomas: results from a three-year endoscopic follow-up study
Nutr Cancer, 49 (2), 131-8
DOI 10.1207/s15327914nc4902_3, PubMed 15489205

Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, Henriksen M, Stray N, Kjellevold O, Vatn M, Moum B, IBSEN Study Group (2004)
Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis
Scand J Gastroenterol, 39 (4), 365-73
DOI 10.1080/00365520310008386, PubMed 15125469

Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, Henriksen M, Stray N, Kjellevold O, Vatn MH, Moum B (2004)
Health-related quality of life in patients with inflammatory bowel disease five years after the inital diagnosis
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 39(2004)4, s. 365-73
BIBSYS 051773643

Førli L, Halse J, Haug E, Bjørtuft O, Vatn MH, Kofstad J, Boe J (2004)
Vitamin D deiciency, bone mineral density and weight in patients advanced pulmonary disease
In Journal of internal medicine, Blackwell Scientific Publ., Oxford, 256(2004)1, S. 56-62
BIBSYS 051783517

Førli L, Halse J, Haug E, Bjørtuft Ø, Vatn M, Kofstad J, Boe J (2004)
Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease
J Intern Med, 256 (1), 56-62
DOI 10.1111/j.1365-2796.2004.01337.x, PubMed 15189366

Hoff G, Grotmol T, Thiis-Evensen E, Bretthauer M, Gondal G, Vatn MH (2004)
Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT)
Gut, 53 (9), 1329-33
DOI 10.1136/gut.2004.039032, PubMed 15306594

Laake KO, Line PD, Grzyb K, Aamodt G, Aabakken L, Røset A, Hvinden AB, Bakka A, Eide J, Bjørneklett A, Vatn MH (2004)
Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA)
Scand J Gastroenterol, 39 (12), 1228-35
DOI 10.1080/00365520410009320, PubMed 15743000

Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Välimäki M, Nordic NE Tumour Group (2004)
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview
Acta Oncol, 43 (7), 617-25
DOI 10.1080/02841860410018575, PubMed 15545182

Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, Haglund C, Knigge U, Vatn MH, Välimäki M, Nordic NE Tumour Group (2004)
Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II-specific NE tumour types
Acta Oncol, 43 (7), 626-36
DOI 10.1080/02841860410018584, PubMed 15545183

Simrén M, Brazier J, Coremans G, Dapoigny M, Müller-Lissner SA, Pace F, Smout AJ, Stockbrügger RW, Vatn MH, Whorwell PJ (2004)
Quality of life and illness costs in irritable bowel syndrome
Digestion, 69 (4), 254-61
DOI 10.1159/000079846, PubMed 15256832

Smout AJ, Azpiroz F, Brummer RJ, Coremans G, Dapoigny M, Müller-Lissner SA, Pace F, Stockbrügger RM, Vatn M, Whorwell PJ (2004)
Technologies in the evaluation of irritable bowel syndrome
Digestion, 69 (3), 158-65
DOI 10.1159/000078185, PubMed 15118394

Spetalen S, Jacobsen MB, Vatn MH, Blomhoff S, Sandvik L (2004)
Visceral sensitivity in irritable bowel syndrome and healthy volunteers: reproducibility of the rectal barostat
Dig Dis Sci, 49 (7-8), 1259-64
DOI 10.1023/b:ddas.0000037821.84014.66, PubMed 15387355

Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM, IBSEN Study Group (2004)
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients
J Hepatol, 41 (2), 209-14
DOI 10.1016/j.jhep.2004.04.024, PubMed 15288468

Publications 2003

Almendingen K, Hofstad B, Vatn MH (2003)
Does a family history of cancer increase the risk of occurrence, growth, and recurrence of colorectal adenomas?
Gut, 52 (5), 747-51
DOI 10.1136/gut.52.5.747, PubMed 12692063

Bernklev T, Henriksen M, Jahnsen J, Lygren I, Sauar J, Stary N, Kjellevold O, Aadland E, Vatn MH, Moum B (2003)
Health related quality of life five years after diagnosisin a prospective follow up study of patients with inflammatory bowel disease
In Gut, British Medical Association, London, 52(2003)suppl 6, s.A40
BIBSYS 041729900

Bernklev T, Moum B, Jahnsen J, Vatn MH (2003)
Variables influencing health related quality of life in patients with inflammatory bowel disease
In Gastroenterology, Gastroenterology, Baltimore, Md., 124(2003)suppl 1, s.A20 abstrakt S1399
BIBSYS 041729730

Bernklev T, Moum B, Jahnsen J, Vatn MH (2003)
Variables influencing health related quality of life (HRQOL) in patients with inflammatory bowel disease (IBD)
In Gastroenterology, Gastroenterology, Baltimore, Md., 124(2003)suppl 1, s.A218 abstrakt S1439
BIBSYS 041729781

Dapoigny M, Stockbrügger RW, Azpiroz F, Collins S, Coremans G, Müller-Lissner S, Oberndorff A, Pace F, Smout A, Vatn M, Whorwell P (2003)
Role of alimentation in irritable bowel syndrome
Digestion, 67 (4), 225-33
DOI 10.1159/000072061, PubMed 12966230

Løvig T, Thorstensen L, Hofstad B, Andersen SN, Clausen OP, Vatn M, Lothe RA, Rognum TO (2003)
Genetic and protein markers related to in situ growth and multiplicity in small sporadic colorectal adenomas
Scand J Gastroenterol, 38 (3), 298-306
DOI 10.1080/00365520310000618, PubMed 12737446

Laake KO, Line PD, Aabakken L, Løtveit T, Bakka A, Eide J, Roseth A, Grzyb K, Bjørneklett A, Vatn MH (2003)
Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis
Scand J Gastroenterol, 38 (4), 409-14
PubMed 12739713

Laake KO, Line PD, Aabakken L, Løtveit T, Bakka A, Eide J, Røsetti A, Grzyb K, Bjørneklett A, Vatn MH (2003)
Assessment of Mucosal Inflammation and Circulation in Response to Probiotics in Patients Operated with Ileal Pouch Anal Anastomosis for Ulcerative Colitis
Scand J Gastroenterol, 38 (4), 409-414
DOI 10.1080/00365520310000906, PubMed 28240145

Laake KO, Line PD, Aabakken T, Lotveit A, Bakka A, Eide J, Røseth AG, Grzyb K, Bjørnklett A, Vatn MH (2003)
Assessment of mucosal inflammation and circulation in response to probiotics om patients operated with ileal pouch anal anastomosis for ulcerative colitis
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)4, s.409-14
BIBSYS 041719425

Moum B, Jahnsen J, Vatn MH, Bernklev T (2003)
Familial occurence og IBD in Ulcerative colitis and Crohn's disease patients and the significance of this for disease behaviour
In Gastroenterology, Gastroenterology, Baltimore, Md., 124(2003)suppl 1, s.A210 abstract S1400
BIBSYS 041734653

Vatn MH (2003)
The CARD15 gene mutation in Crohn disease
Scand J Gastroenterol, 38 (11), 1105-6
DOI 10.1080/00365520310005424, PubMed 14686712

Publications 2002

Almendingen K, Hofstad B, Vatn MH (2002)
Does intake of alcohol increase the risk of presence and growth of colorectal adenomas followed-up in situ for three years?
Scand J Gastroenterol, 37 (1), 80-7
DOI 10.1080/003655202753387400, PubMed 11843041

Almendingen K, Hofstad B, Vatn MH (2002)
Lifestyle-related factors and colorectal polyps: preliminary results from a Norwegian follow-up and intervention study
Eur J Cancer Prev, 11 (2), 153-8
DOI 10.1097/00008469-200204000-00007, PubMed 11984133

Blomhoff S, Diseth TH, Jacobsen MB, Vatn M (2002)
[Irritable bowel syndrome--a multifactorial disease in children and adults]
Tidsskr Nor Laegeforen, 122 (12), 1213-7
PubMed 12089850

Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, Skovlund E, Tveit KM, Vatn MH, Hoff G (2002)
Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention)
Scand J Gastroenterol, 37 (5), 568-73
DOI 10.1080/00365520252903125, PubMed 12059059

Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Jahnsen J, Moum B, Klump B, Krawczak M, Mirza MM, Foelsch UR, Vatn M, Schreiber S (2002)
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study
Lancet, 359 (9318), 1661-5
DOI 10.1016/S0140-6736(02)08590-2, PubMed 12020527

Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Jahnsen J, Moum B, Klump M, Krawczak M, Mirza MM, Foelsch UR, Vatn MH, Schreiber S (2002)
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study
In Lancet, Lancet Ltd., London, 359(2002)nr 9318, s. 1661-1665
BIBSYS 031255922

Hoff G, Thiis-Evensen E, Vatn M (2002)
Screening for sporadic colorectal cancer
Endoscopy, 34 (6), 508; author reply 509-10
DOI 10.1055/s-2002-31993, PubMed 12048642

International Budesonide-Mesalazine Study Group, Thomsen OØ, Cortot A, Jewell DP, Wright JP, Winter T, Veloso FT, Vatn MH, Petterson E (2002)
Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life
In American journal of gastroenterology, Elsevier, New York, 97(2002)nr 3, s.649-653
BIBSYS 031373143

Ljung T, Staun M, Grove O, Fausa O, Vatn MH, Hellström PM (2002)
Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab
Scand J Gastroenterol, 37 (9), 1108-10
DOI 10.1080/003655202320378338, PubMed 12374238

Thomsen OO, Cortot A, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E, Int Budesonide-Mesalazine Study Gr (2002)
Budesonide and Mesalazine in active Crohn's disease: A comparison of the effects on quality of life
Am. J. Gastroenterol., 97 (3), PII S0002-9270(01)04106-5-653

Thomsen OO, Cortot A, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E, International Budesonide-Mesalazine Study Group (2002)
Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life
Am J Gastroenterol, 97 (3), 649-53
DOI 10.1111/j.1572-0241.2002.05544.x, PubMed 11922560

Publications 2001

Almendingen K, Hofstad B, Trygg K, Hoff G, Hussain A, Vatn M (2001)
Current diet and colorectal adenomas: a case-control study including different sets of traditionally chosen control groups
Eur J Cancer Prev, 10 (5), 395-406
DOI 10.1097/00008469-200110000-00003, PubMed 11711754

Almendingen K, Hofstad B, Vatn MH (2001)
Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years?
Am J Gastroenterol, 96 (7), 2238-46
DOI 10.1111/j.1572-0241.2001.03942.x, PubMed 11467659

Almendingen K, Trygg K, Hofstad B, Veierød MB, Vatn MH (2001)
Results from two repeated 5 day dietary records with a 1 y interval among patients with colorectal polyps
Eur J Clin Nutr, 55 (5), 374-9
DOI 10.1038/sj.ejcn.1601166, PubMed 11378811

Førli L, Bjørtuft Ø, Vatn M, Kofstad J, Boe J (2001)
A study of intensified dietary support in underweight candidates for lung transplantation
Ann Nutr Metab, 45 (4), 159-68
DOI 10.1159/000046724, PubMed 11463999

Førli L, Pedersen JI, Bjørtuft O, Vatn M, Boe J (2001)
Dietary support to underweight patients with end-stage pulmonary disease assessed for lung transplantation
Respiration, 68 (1), 51-7
DOI 10.1159/000050463, PubMed 11223731

Hoff G, Thiis-Evensen E, Grotmol T, Sauar J, Vatn MH, Moen IE (2001)
Do undesirable effects of screening affect all-cause mortality in flexible sigmoidoscopy programmes? Experience from the Telemark Polyp Study 1983-1996
Eur J Cancer Prev, 10 (2), 131-7
DOI 10.1097/00008469-200104000-00003, PubMed 11330453

Müller-Lissner SA, Bollani S, Brummer RJ, Coremans G, Dapoigny M, Marshall JK, Muris JW, Oberndorff-Klein Wolthuis A, Pace F, Rodrigo L, Stockbrügger R, Vatn MH (2001)
Epidemiological aspects of irritable bowel syndrome in Europe and North America
Digestion, 64 (3), 200-4
DOI 10.1159/000048862, PubMed 11786669

Schreiber S, Campieri M, Colombel JF, van Deventer SJ, Feagan B, Fedorak R, Forbes A, Gassull M, Gendre JP, van Hogezand RA, Lofberg R, Modigliani R, Pallone F, Petritsch W, Prantera C, Rampton D, Seibold F, Vatn M, Zeitz M, Rutgeerts P, BMBF Competence Network "Inflammatory Bowel disease" (2001)
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003
Int J Colorectal Dis, 16 (1), 1-11; discussion 12-3
DOI 10.1007/s003840100285, PubMed 11317691

Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH (2001)
The effect of attending a flexible sigmoidoscopic screening program on the prevalence of colorectal adenomas at 13-year follow-up
Am J Gastroenterol, 96 (6), 1901-7
DOI 10.1111/j.1572-0241.2001.03891.x, PubMed 11419846

Vatn MH (2001)
[Ulcerative colitis]
Tidsskr Nor Laegeforen, 121 (3), 280
PubMed 11242864

Wester AL, Vatn MH, Fausa O (2001)
Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998
Inflamm Bowel Dis, 7 (4), 295-300
DOI 10.1097/00054725-200111000-00003, PubMed 11720318

Publications 2000

Almendingen K, Hofstad B, Trygg K, Hoff G, Hussain A, Vatn MH (2000)
Smoking and colorectal adenomas: a case-control study
Eur J Cancer Prev, 9 (3), 193-203
DOI 10.1097/00008469-200006000-00008, PubMed 10954259

Blomhoff S, Spetalen S, Jacobsen MB, Vatn M, Malt UF (2000)
Rectal tone and brain information processing in irritable bowel syndrome
Dig Dis Sci, 45 (6), 1153-9
DOI 10.1023/a:1005550002622, PubMed 10877231

Blomhoff S, Spetalen S, Jacobsen MB, Vatn M, Malt UF (2000)
Intestinal reactivity to words with emotional content and brain information processing in irritable bowel syndrome
Dig Dis Sci, 45 (6), 1160-5
DOI 10.1023/a:1005502119461, PubMed 10877232

Campieri M, Cohen Z, Griffiths A, Ejderhamm J, Lofberg R, Rutgeerts P, Sachar D, Tremaine W, Vatn M (2000)
Session II and III panel discussion
Drugs Today, 36 G, 93-101

Førli L, Pedersen JI, Bjørtuft, Vatn M, Kofstad J, Boe J (2000)
Serum amino acids in relation to nutritional status, lung function and energy intake in patients with advanced pulmonary disease
Respir Med, 94 (9), 868-74
DOI 10.1053/rmed.2000.0830, PubMed 11001078

Jacobsen MB, Aukrust P, Kittang E, Müller F, Ueland T, Bratlie J, Bjerkeli V, Vatn MH (2000)
Relation between food provocation and systemic immune activation in patients with food intolerance
Lancet, 356 (9227), 400-1
DOI 10.1016/s0140-6736(00)02536-8, PubMed 10972377

Lofberg R, Cohen Z, Cortot A, Ejderhamm J, Gomollon F, Graffner H, Griffiths A, Lobo A, Rutgeerts P, Sachar D, Stange E, Tremaine W, Vatn M (2000)
Case presentation: Extensive colorectal Crohn's disease
Drugs Today, 36 G, 121-128

Smout A, Azpiroz F, Coremans G, Dapoigny M, Collins S, Müller-Lissner S, Pace F, Stockbrügger R, Vatn M, Whorwell P (2000)
Potential pitfalls in the differential diagnosis of irritable bowel syndrome
Digestion, 61 (4), 247-56
DOI 10.1159/000007765, PubMed 10878451

Thiis-Evensen E, Hoff GS, Sauar J, Vatn MH (2000)
Patient tolerance of colonoscopy without sedation during screening examination for colorectal polyps
Gastrointest Endosc, 52 (5), 606-10
DOI 10.1067/mge.2000.109804, PubMed 11060183

Vatn M, Cohen Z, Cortot A, Lobo A, Rutgeerts P, Sachar D, Tremaine W (2000)
Case presentation: Postoperative prophylaxis
Drugs Today, 36 G, 115-119

Publications 1999

Moum B, Ekbom A, Vatn MH, Elgjo K (1999)
Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time
Am J Gastroenterol, 94 (6), 1564-9
DOI 10.1111/j.1572-0241.1999.01145.x, PubMed 10364026

Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH (1999)
Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study I
Scand J Gastroenterol, 34 (4), 414-20
DOI 10.1080/003655299750026443, PubMed 10365903

Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH (1999)
Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years
Gut, 45 (6), 834-9
DOI 10.1136/gut.45.6.834, PubMed 10562581

Publications 1998

Førli L, Oppedal B, Skjelle K, Vatn M (1998)
Validation of a self-administered form for recording food intake in hospital patients
Eur J Clin Nutr, 52 (12), 929-33
DOI 10.1038/sj.ejcn.1600667, PubMed 9881889

Hofstad B, Almendingen K, Vatn M, Andersen SN, Owen RW, Larsen S, Osnes M (1998)
Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants
Digestion, 59 (2), 148-56
DOI 10.1159/000007480, PubMed 9586828

Hofstad B, Vatn MH, Andersen SN, Owen RW, Larsen S, Osnes M (1998)
The relationship between faecal bile acid profile with or without supplementation with calcium and antioxidants on recurrence and growth of colorectal polyps
Eur J Cancer Prev, 7 (4), 287-94
DOI 10.1097/00008469-199808000-00004, PubMed 9806117

Lygren I, Andersen LP, Lerang F, Kleveland PM, Farup P, Vatn M, Aursnes I (1998)
[Treatment of Helicobacter pylori infection]
Tidsskr Nor Laegeforen, 118 (29), 4511-4
PubMed 9889634

Thomsen OO, Cortot A, Jewell D, Wright JP, Winter T, Veloso FT, Vatn M, Persson T, Pettersson E (1998)
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group
N Engl J Med, 339 (6), 370-4
DOI 10.1056/NEJM199808063390603, PubMed 9691103

Publications 1997

Hofstad B, Vatn M (1997)
Growth rate of colon polyps and cancer
Gastrointest Endosc Clin N Am, 7 (3), 345-63
PubMed 9177139

Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O (1997)
Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway
Gut, 40 (3), 328-32
DOI 10.1136/gut.40.3.328, PubMed 9135520

Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, Schulz T, Stray N, Fausa O (1997)
Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93
Scand J Gastroenterol, 32 (10), 1005-12
DOI 10.3109/00365529709011217, PubMed 9361173

Vatn MH (1997)
Food intolerance and psychosomatic experience
Scand J Work Environ Health, 23 Suppl 3, 75-8
PubMed 9456071

Vatn MH (1997)
Symptoms and manifestations of food intolerance
Environ Toxicol Pharmacol, 4 (1-2), 51-3
DOI 10.1016/s1382-6689(97)10041-2, PubMed 21781799

Publications 1996

Efskind PS, Bernklev T, Vatn MH (1996)
A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome
Scand J Gastroenterol, 31 (5), 463-8
DOI 10.3109/00365529609006766, PubMed 8734343

Hoff G, Sauar J, Hofstad B, Vatn MH (1996)
The Norwegian guidelines for surveillance after polypectomy: 10-year intervals
Scand J Gastroenterol, 31 (9), 834-6
DOI 10.3109/00365529609051989, PubMed 8888428

Hoff G, Sauar J, Vatn MH, Larsen S, Langmark F, Moen IE, Foerster A, Thiis-Evensen E (1996)
Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study
Scand J Gastroenterol, 31 (10), 1006-10
DOI 10.3109/00365529609003121, PubMed 8898422

Hofstad B, Vatn MH, Andersen SN, Huitfeldt HS, Rognum T, Larsen S, Osnes M (1996)
Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years
Gut, 39 (3), 449-56
DOI 10.1136/gut.39.3.449, PubMed 8949653

Jacobsen MB, Vatn MH (1996)
[Sick of food? Knowledge and hypothesis on food intolerance]
Nord Med, 111 (4), 109-12, 118
PubMed 8649968

Krajci P, Meling GI, Andersen SN, Hofstad B, Vatn MH, Rognum TO, Brandtzaeg P (1996)
Secretory component mRNA and protein expression in colorectal adenomas and carcinomas
Br J Cancer, 73 (12), 1503-10
DOI 10.1038/bjc.1996.284, PubMed 8664120

Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Sauar J, Schulz T, Stray N (1996)
Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists
Scand J Gastroenterol, 31 (4), 362-6
DOI 10.3109/00365529609006411, PubMed 8726304

Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Stray N, Sauar J, Schulz T (1996)
Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists
Scand J Gastroenterol, 31 (4), 355-61
DOI 10.3109/00365529609006410, PubMed 8726303

Moum B, Aadland E, Ekbom A, Vatn MH (1996)
Seasonal variations in the onset of ulcerative colitis
Gut, 38 (3), 376-8
DOI 10.1136/gut.38.3.376, PubMed 8675089

Publications 1995

Almendingen K, Trygg K, Larsen S, Hofstad B, Vatn MH (1995)
Dietary factors and colorectal polyps: a case-control study
Eur J Cancer Prev, 4 (3), 239-46
DOI 10.1097/00008469-199506000-00005, PubMed 7647692

Almendingen K, Trygg K, Vatn M (1995)
[Influence of the diet on cell proliferation in the large bowel and the rectum. Does a strict vegetarian diet reduct the risk of intestinal cancer?]
Tidsskr Nor Laegeforen, 115 (18), 2252-6
PubMed 7652722

Boberg KM, Brinch L, Vatn M (1995)
Crohn disease and the myelodysplastic syndrome
Ann Intern Med, 122 (5), 395
DOI 10.7326/0003-4819-122-5-199503010-00023, PubMed 7847659

HOFSTAD B, VATN M (1995)
SMALL COLORECTAL POLYPS - REPLY
Scand. J. Gastroenterol., 30 (3), 288

Jacobsen MB, Hanssen LE, Kolmannskog F, Schrumpf E, Vatn MH, Bergan A (1995)
Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study
Scand J Gastroenterol, 30 (8), 789-96
DOI 10.3109/00365529509096329, PubMed 7481548

Lothe RA, Andersen SN, Hofstad B, Meling GI, Peltomäki P, Heim S, Brøgger A, Vatn M, Rognum TO, Børresen AL (1995)
Deletion of 1p loci and microsatellite instability in colorectal polyps
Genes Chromosomes Cancer, 14 (3), 182-8
DOI 10.1002/gcc.2870140305, PubMed 8589034

Moum B, Vatn MH, Ekbom A, Fausa O, Aadland E, Lygren I, Sauar J, Schulz T (1995)
Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists
Digestion, 56 (5), 377-81
DOI 10.1159/000201262, PubMed 8549880

Thomson AB, Wright JP, Vatn M, Bailey RJ, Rachmilewitz D, Adler M, Wilson-Lynch KA (1995)
Mesalazine (Mesasal/Claversal) 1.5 g b.d. vs. placebo in the maintenance of remission of patients with Crohn's disease
Aliment Pharmacol Ther, 9 (6), 673-83
DOI 10.1111/j.1365-2036.1995.tb00438.x, PubMed 8824656

Vatn MH, Grimstad IA, Thorsen L, Kittang E, Refnin I, Malt U, Løvik A, Langeland T, Naalsund A (1995)
Adverse reaction to food: assessment by double-blind placebo-controlled food challenge and clinical, psychosomatic and immunologic analysis
Digestion, 56 (5), 421-8
DOI 10.1159/000201270, PubMed 8549887

Publications 1994

Hofstad B, Vatn M, Larsen S, Huitfeldt HS, Osnes M (1994)
In situ measurement of colorectal polyps to compare video and fiberoptic endoscopes
Endoscopy, 26 (5), 461-5
DOI 10.1055/s-2007-1009004, PubMed 7956955

Hofstad B, Vatn M, Larsen S, Osnes M (1994)
Growth of colorectal polyps: recovery and evaluation of unresected polyps of less than 10 mm, 1 year after detection
Scand J Gastroenterol, 29 (7), 640-5
DOI 10.3109/00365529409092485, PubMed 7939401

Publications 1993

Vatn MH (1993)
Screening for colorectal cancer
Lancet, 341 (8855), 1279
PubMed 8098417

Publications 1992

Hoff G, Moen IE, Mowinckel P, Rosef O, Nordbö E, Sauar J, Vatn MH, Torgrimsen T (1992)
Drinking water and the prevalence of colorectal adenomas: an epidemiologic study in Telemark, Norway
Eur J Cancer Prev, 1 (6), 423-8
DOI 10.1097/00008469-199210000-00005, PubMed 1334444

Hofstad B, Vatn M, Hoff G, Larsen S, Osnes M (1992)
Growth of colorectal polyps: design of a prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps
Eur J Cancer Prev, 1 (6), 415-22
PubMed 1463996

Hofstad B, Vatn M, Larsen S, Osnes M (1992)
Reliability of in situ measurements of colorectal polyps
Scand J Gastroenterol, 27 (1), 59-64
DOI 10.3109/00365529209011168, PubMed 1736344

Publications 1991

Hoff G, Vatn MH (1991)
Colonic adenoma: natural history
Dig Dis, 9 (2), 61-9
DOI 10.1159/000171293, PubMed 2036733

Vatn MH, Guldvog I, Berstad A, Bjørneklett A, Melby K, Skar V, Aase S (1991)
[Should ulcer treatment be aimed against Helicobacter pylori?]
Tidsskr Nor Laegeforen, 111 (2), 219
PubMed 1998186

Vatn MH, Hoff G, Clausen OP (1991)
Epidemiology and histopathogenesis of colorectal cancer
Eur J Cancer Prev, 1 Suppl 2, 5-12
DOI 10.1097/00008469-199110002-00002, PubMed 1842733

Publications 1990

Bjøro K, Vatn M, Schrumpf E, Ganes T, Lundar T, Bergan A (1990)
[Liver transplantation in fulminant hepatic failure]
Tidsskr Nor Laegeforen, 110 (26), 3372-5
PubMed 2256061

Publications 1989

Jahnsen J, Vatn MH (1989)
[Radiation injury of the intestine]
Tidsskr Nor Laegeforen, 109 (25), 2557-8
PubMed 2814976

Vatn MH, Aursnes I, Aadland E, Rydning A, Guldvog I (1989)
[Non-ulcer dyspepsia. Classification and differentiation from organic disease]
Tidsskr Nor Laegeforen, 109 (19-21), 2024-5
PubMed 2749693

Vatn MH, Hoff G (1989)
Colorectal cancer prevention. In search of risk factors and increased effectiveness of surveillance programs
Scand J Gastroenterol, 24 (9), 1025-30
DOI 10.3109/00365528909089251, PubMed 2595263

Vatn MH, Hoff G, Clausen OP, Foerster A (1989)
Enzyme patterns and flow cytometric DNA measurements in colorectal hyperplastic polyps and tubular adenomas less than five millimeters
Scand J Gastroenterol, 24 (9), 1031-8
DOI 10.3109/00365528909089252, PubMed 2595264

Publications 1988

Hoff G, Moen IE, Trygg K, Frölich W, Foerster A, Vatn M, Sauar J, Larsen S (1988)
Colorectal adenomas and food. A prospective study of change in volume and total mass of adenomas in man
Scand J Gastroenterol, 23 (10), 1253-8
DOI 10.3109/00365528809090201, PubMed 3249923

Publications 1987

Hoff G, Vatn MH, Larsen S (1987)
Relationship between tobacco smoking and colorectal polyps
Scand J Gastroenterol, 22 (1), 13-6
DOI 10.3109/00365528708991849, PubMed 3563406

Aadland E, Fausa O, Vatn M, Cohen H, Quinlan D (1987)
Protection by misoprostol against naproxen-induced gastric mucosal damage
Am J Med, 83 (1A), 37-40
DOI 10.1016/0002-9343(87)90577-8, PubMed 3113244

Publications 1986

Hebnes K, Selbekk BH, Vatn MH (1986)
A double-blind crossover study of the effect of a chromone carboxylic acid, FPL 52694, on overnight fasting gastric acid secretion
Scand J Gastroenterol, 21 (8), 965-8
DOI 10.3109/00365528608996405, PubMed 3095913

Hoff G, Foerster A, Vatn MH, Sauar J, Larsen S (1986)
Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection
Scand J Gastroenterol, 21 (7), 853-62
DOI 10.3109/00365528609011130, PubMed 3775252

Hoff G, Moen IE, Trygg K, Frølich W, Sauar J, Vatn M, Gjone E, Larsen S (1986)
Epidemiology of polyps in the rectum and sigmoid colon. Evaluation of nutritional factors
Scand J Gastroenterol, 21 (2), 199-204
DOI 10.3109/00365528609034647, PubMed 3012767

Vatn MH, Gjone E, Mogstad TE (1986)
[Abdominal complaints of unknown origin. A prospective study]
Tidsskr Nor Laegeforen, 106 (8), 646-9
PubMed 3705026

Publications 1985

Hoff G, Clausen OP, Fjordvang H, Norheim A, Foerster A, Vatn MH (1985)
Epidemiology of polyps in the rectum and sigmoid colon. Size, enzyme levels, DNA distributions, and nuclear diameter in polyps of the large intestine
Scand J Gastroenterol, 20 (8), 983-9
DOI 10.3109/00365528509088859, PubMed 4081637

Hoff G, Foerster A, Vatn MH, Gjone E (1985)
Epidemiology of polyps in the rectum and sigmoid colon. Histological examination of resected polyps
Scand J Gastroenterol, 20 (6), 677-83
DOI 10.3109/00365528509089194, PubMed 4035287

Hoff G, Vatn M (1985)
Epidemiology of polyps in the rectum and sigmoid colon. Endoscopic evaluation of size and localization of polyps
Scand J Gastroenterol, 20 (3), 356-60
DOI 10.3109/00365528509091664, PubMed 4001845

Hoff G, Vatn M, Gjone E, Larsen S, Sauar J (1985)
Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study
Scand J Gastroenterol, 20 (3), 351-5
DOI 10.3109/00365528509091663, PubMed 4001844

Vatn MH, Fausa O, Gjone E (1985)
Diagnostic value of gastrointestinal endoscopy in patients with uncharacteristic abdominal disorders
Scand J Gastroenterol, 20 (5), 636-40
DOI 10.3109/00365528509089709, PubMed 4023627

Vatn MH, Jellum E, Elgjo K, Bergan A (1985)
Enzyme activity and protein patterns as premalignant markers in mucosal biopsy specimens from the large intestine
Scand J Gastroenterol Suppl, 107, 1-7
DOI 10.3109/00365528509099746, PubMed 3856932

Vatn MH, Mogstad TE, Gjone E (1985)
A prospective study of patients with uncharacteristic abdominal disorders
Scand J Gastroenterol, 20 (4), 407-14
DOI 10.3109/00365528509089672, PubMed 3895379

Vatn MH, Myren J, Serck-Hanssen A (1985)
The distribution of polyps in the large intestine
Ann Gastroenterol Hepatol (Paris), 21 (4), 239-45
PubMed 4073821

Vatn MH, Tjora S, Elgjo K, Norheim A, Bergan A (1985)
Lactate dehydrogenase isoenzymes in mucosal biopsy specimens from patients with ulcerative colitis
Scand J Gastroenterol, 20 (8), 929-32
DOI 10.3109/00365528509088849, PubMed 4081630

Publications 1984

Jellum E, Thorsrud AK, Vatn MH, Grimstad IA, Brennhovd I, Tveit KM, Pihl A (1984)
Detection of cancer-related proteins by two-dimensional electrophoresis
Ann N Y Acad Sci, 428, 173-85
DOI 10.1111/j.1749-6632.1984.tb12294.x, PubMed 6588905

Vatn MH, Elgjo K, Bergan A (1984)
Distribution of dysplasia in ulcerative colitis
Scand J Gastroenterol, 19 (7), 893-5
DOI 10.1080/00365521.1984.12005827, PubMed 6531658

Vatn MH, Elgjo K, Norheim A, Bergan A (1984)
Measurement of enzyme activity in colonic biopsies: a test for premalignancy in ulcerative colitis?
Scand J Gastroenterol, 19 (7), 889-92
DOI 10.1080/00365521.1984.12005826, PubMed 6531657

Publications 1983

Kolmannskog F, Vatn MH, Swensen T, Aakhus T, Gjone E (1983)
Computer tomography of the abdomen in patients with uncharacteristic abdominal disturbances
Scand J Gastroenterol, 18 (2), 225-7
DOI 10.3109/00365528309181587, PubMed 6673051

Larssen TB, Skarpass E, Lowe P, Stokkeland M, Vatn M (1983)
[Radiographic examination of the stomach and duodenum by the double contrast method compared with endoscopy. A prospective study]
Tidsskr Nor Laegeforen, 103 (15), 1252-5
PubMed 6349007

Swensen T, Vatn MH, Kolmannskog F, Aakhus T, Gjone E (1983)
Abdominal ultrasonography in patients with uncharacteristic abdominal symptoms
Scand J Gastroenterol, 18 (8), 1069-71
DOI 10.3109/00365528309181842, PubMed 6673076

Vatn MH, Schrumpf E, Talseth T (1983)
Effect of cimetidine on intrinsic factor secretion stimulated by different doses of pentagastrin in patients with impaired renal function
Scand J Gastroenterol, 18 (8), 1109-14
DOI 10.3109/00365528309181849, PubMed 6424229

Publications 1982

Arva P, Havig O, Skjennald A, Johannesen J, Vatn MH (1982)
[New diagnostic possibilities in colorectal hemorrhage]
Tidsskr Nor Laegeforen, 102 (29), 1508-10
PubMed 6984795

Kolmannskog F, Swensen T, Vatn MH, Larsen S (1982)
Computed tomography and ultrasound of the normal pancreas
Acta Radiol Diagn (Stockh), 23 (5), 443-51
DOI 10.1177/028418518202300502, PubMed 7158408

Thorsrud AK, Vatn MH, Jellum E (1982)
Two-dimensional electrophoretic patterns of proteins of normal mucosa, polyps, and carcinomas of the large intestine
Clin Chem, 28 (4 Pt 2), 884-9
PubMed 7074880

Vatn MH, Stalsberg H (1982)
The prevalence of polyps of the large intestine in Oslo: an autopsy study
Cancer, 49 (4), 819-25
DOI 10.1002/1097-0142(19820215)49:4<819::aid-cncr2820490435>3.0.co;2-d, PubMed 7055790

Vatn MH, Tjora S, Arva PH, Serck-Hanssen A, Stromme JH (1982)
Enzymatic characteristics of tubular adenomas and carcinomas of the large intestine
Gut, 23 (3), 194-7
DOI 10.1136/gut.23.3.194, PubMed 7068044

Publications 1980

Vatn MH, Arva PH, Serck-Hanssen A (1980)
[Campylobacter colitis]
Tidsskr Nor Laegeforen, 100 (11), 617-9
PubMed 7385121

Vatn MH, Schrumpf E, Hanssen KF, Myren J (1980)
A small dose of somatostatin inhibits the secretin stimulated secretion of bicarbonate, amylase, and chymotrypsin in man
J Endocrinol Invest, 3 (3), 279-82
DOI 10.1007/BF03348276, PubMed 6159391

Publications 1978

Schrumpf E, Vatn MH, Hanssen KF, Myren J (1978)
A small dose of somatostatin inhibits the pentagastrin stimulated gastric secretion of acid, pepsin and intrinsic factor in man
Clin Endocrinol (Oxf), 8 (5), 391-5
DOI 10.1111/j.1365-2265.1978.tb02173.x, PubMed 348347

Publications 1977

Schrumpf E, Myren J, Semb LS, Vatn MH (1977)
The effect of atropine on insulin stimulated gastric secretion and gastrin release
Mater Med Pol, 9 (2), 101-3
PubMed 895183

Vatn MH, Myren J, Serck-Hanssea A (1977)
[Comparison of lactose absorption, lactase activity and histological changes in blind biopsies from the small intestine]
Tidsskr Nor Laegeforen, 97 (8), 388-9
PubMed 847700

Vatn MH, Schrumpf E, Hanssen KF, Myren J (1977)
The effect of somatostatin on pentagastrin-stimulated gastric secretion and on plasma gastrin in man
Scand J Gastroenterol, 12 (7), 833-9
DOI 10.3109/00365527709181727, PubMed 339322

Publications 1976

Schrumpf E, Vatn MH, Hanssen KF, Semb LS, Myren J (1976)
The effect of somatostatin on gastrin release and gastric secretion
Scand J Gastroenterol Suppl, 42, 41-2
PubMed 1070794

Schrumpf E, Vatn MH, Hanssen KF, Semb S, Myren J (1976)
Somatostatin inhibits insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF) in duodenal ulcer patients
Scand J Gastroenterol, 11 (5), 517-20
PubMed 785589

Vatn MH, Myren J (1976)
Gastric secretory response to different doses of carbachol and pentagastrin in man
Scand J Gastroenterol, 11 (4), 421-5
PubMed 779004

Publications 1975

Vatn MH (1975)
The effect of duodenal juice on the intrinsic factor (IF) activity in gastric juice
Scand J Gastroenterol, 10 (1), 49-59
PubMed 235783

Vatn MH (1975)
Review: Gastric intrinsic factor secretion
Scand J Gastroenterol, 10 (4), 337-8
PubMed 1153926

Vatn MH, Schrumpf E, Myren J (1975)
The effect of carbachol and pentagastrin on the gastric secretion of acid pepsin, and intrinsic factor (IF) in man
Scand J Gastroenterol, 10 (1), 55-8
PubMed 235784

Vatn MH, Semb LS, Schrumpf E (1975)
The effect of atropine and vagotomy on the secretion of gastric intrinsic factor (IF) in man
Scand J Gastroenterol, 10 (1), 59-64
PubMed 235785

Publications 1974

Schrumpf E, Vatn MH, Semb LS (1974)
Effect of atropine on insulin-stimulated gastrin release and gastric secretion of acid, pepsin, and intrinsic factor (IF)
Scand J Gastroenterol, 9 (7), 665-9
PubMed 4610710

Vatn MH (1974)
The effect of pentagastrin, exogenous secretin, and cholecystokinin (CCK) on the intrinsic factor (IF) secretion in man
Scand J Gastroenterol Suppl, 29, 53-6
PubMed 4610721

Vatn MH (1974)
Studies on the regulation of gastric intrinsic factor secretion in man
Research laboratory of gastroenterology, Department IX, Internal Medicine, Ullevål University Hospital, Oslo, 1 b. (flere pag.)
BIBSYS 991371801

Vatn MH, Berstad A, Myren J (1974)
The effect of exogenous secretin and cholecystokinin (CCK) on pentagastrin-stimulated intrinsic factor (IF) secretion in man
Scand J Gastroenterol, 9 (3), 313-18
PubMed 4605241

Vatn MH, Berstad A, Schrumpf E (1974)
The effect of calcium and pentagastrin on the gastric secretion of acid, pepsin, and intrinsic factor (IF) in man
Scand J Gastroenterol, 9 (7), 697-701
PubMed 4610713

Vatn MH, Petersen H, Myren J (1974)
The effect of graded doses of pentagastrin and secretin on the intrinsic factor (IF) secretion in man
Scand J Gastroenterol, 9 (7), 691-5
PubMed 4610712

Publications 1973

Vatn MH (1973)
Haemoglobin-coated charcoal for estimation of gastric intrinsic factor
Scand J Gastroenterol, 8 (8), 755-60
PubMed 4771117